Severe gastrointestinal involvement in systemic sclerosis: report of five cases and review of the literature
- PMID: 15692963
- DOI: 10.1016/j.semarthrit.2004.08.009
Severe gastrointestinal involvement in systemic sclerosis: report of five cases and review of the literature
Abstract
Objective: To review current literature on the gastrointestinal tract (GIT) manifestations of systemic sclerosis (SSc) and to report on 5 patients with severe gastrointestinal SSc.
Materials and methods: The clinical course and histopathology of 5 patients are described. A review of the medical literature registered in MedLine and PreMedLine databases from 1996 through mid-2004 was performed using the keywords systemic sclerosis and scleroderma and combining them with text words such as gastric, gastrointestinal, anorectal, colonic, and hepatic.
Results: All 5 patients had severe GIT involvement: 4 with diffuse cutaneous SSc (dcSSc) and 1 with limited cutaneous SSc (lcSSc). Autopsy results of 2 patients who died from severe malnutrition and aspiration pneumonia are presented. Literature review includes involvement from oral cavity to anus with varying degrees of severity. Most GIT manifestations result from dysmotility secondary to infiltration of the gastrointestinal wall with fibrous tissue and can cause life-threatening malabsorption and malnutrition. Diagnostic tests, pathology, and treatments of GIT SSc are reviewed.
Conclusions: GIT involvement in SSc can be severely debilitating and even life-threatening. Although morbidity is inevitable, appropriate supportive treatment can prolong survival.
Relevance: GI complications of SSc cause significant morbidity and mortality.
Similar articles
-
Determinants of morbidity and mortality of systemic sclerosis in Canada.Semin Arthritis Rheum. 2010 Feb;39(4):269-77. doi: 10.1016/j.semarthrit.2008.06.002. Epub 2008 Aug 15. Semin Arthritis Rheum. 2010. PMID: 18706680
-
Severe organ involvement in systemic sclerosis with diffuse scleroderma.Arthritis Rheum. 2000 Nov;43(11):2437-44. doi: 10.1002/1529-0131(200011)43:11<2437::AID-ANR10>3.0.CO;2-U. Arthritis Rheum. 2000. PMID: 11083266
-
Characteristics of patients with early systemic sclerosis and severe gastrointestinal tract involvement.J Rheumatol. 2007 Oct;34(10):2050-5. J Rheumatol. 2007. PMID: 17924608
-
Esophageal involvement in scleroderma: gastroesophageal reflux, the common problem.Semin Arthritis Rheum. 2006 Dec;36(3):173-81. doi: 10.1016/j.semarthrit.2006.08.002. Epub 2006 Oct 11. Semin Arthritis Rheum. 2006. PMID: 17045629 Review.
-
Watermelon stomach following and preceding systemic sclerosis.Semin Arthritis Rheum. 2000 Oct;30(2):127-31. doi: 10.1053/sarh.2000.9623. Semin Arthritis Rheum. 2000. PMID: 11071584 Review.
Cited by
-
Calcium channel blockers and esophageal sclerosis: should we expect exacerbation of interstitial lung disease?Case Rep Gastroenterol. 2012 Jan;6(1):82-7. doi: 10.1159/000336584. Epub 2012 Jan 31. Case Rep Gastroenterol. 2012. PMID: 22423244 Free PMC article.
-
Systemic sclerosis gastrointestinal dysmotility: risk factors, pathophysiology, diagnosis and management.Nat Rev Rheumatol. 2023 Mar;19(3):166-181. doi: 10.1038/s41584-022-00900-6. Epub 2023 Feb 6. Nat Rev Rheumatol. 2023. PMID: 36747090 Review.
-
Exocrine pancreatic function is preserved in systemic sclerosis.Arthritis Res Ther. 2019 Feb 12;21(1):52. doi: 10.1186/s13075-019-1840-z. Arthritis Res Ther. 2019. PMID: 30755261 Free PMC article.
-
Slow Colonic Transit in Systemic Sclerosis: An Objective Assessment of Risk Factors and Clinical Phenotype.Arthritis Care Res (Hoboken). 2023 Feb;75(2):289-298. doi: 10.1002/acr.24767. Epub 2022 Sep 13. Arthritis Care Res (Hoboken). 2023. PMID: 34369086 Free PMC article.
-
Managing gastrointestinal complications in patients with systemic sclerosis.Curr Treat Options Gastroenterol. 2020 Dec;18:531-544. doi: 10.1007/s11938-020-00314-x. Epub 2020 Nov 13. Curr Treat Options Gastroenterol. 2020. PMID: 34305387 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical